1. Home
  2. EVLV vs TBPH Comparison

EVLV vs TBPH Comparison

Compare EVLV & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Evolv Technologies Holdings Inc.

EVLV

Evolv Technologies Holdings Inc.

HOLD

Current Price

$5.06

Market Cap

994.7M

Sector

Technology

ML Signal

HOLD

Logo Theravance Biopharma Inc.

TBPH

Theravance Biopharma Inc.

HOLD

Current Price

$17.03

Market Cap

908.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EVLV
TBPH
Founded
2013
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Computer peripheral equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
994.7M
908.9M
IPO Year
2020
2013

Fundamental Metrics

Financial Performance
Metric
EVLV
TBPH
Price
$5.06
$17.03
Analyst Decision
Strong Buy
Buy
Analyst Count
4
6
Target Price
$9.13
$18.40
AVG Volume (30 Days)
1.8M
376.3K
Earning Date
05-12-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
41.18
279.13
EPS
N/A
N/A
Revenue
$145,905,000.00
$15,386,000.00
Revenue This Year
$21.67
$8.46
Revenue Next Year
$19.50
N/A
P/E Ratio
N/A
N/A
Revenue Growth
40.48
N/A
52 Week Low
$4.61
$13.08
52 Week High
$8.81
$21.03

Technical Indicators

Market Signals
Indicator
EVLV
TBPH
Relative Strength Index (RSI) 37.13 61.80
Support Level $4.87 $16.80
Resistance Level $5.86 $17.17
Average True Range (ATR) 0.20 0.05
MACD -0.05 0.01
Stochastic Oscillator 0.01 70.73

Price Performance

Historical Comparison
EVLV
TBPH

About EVLV Evolv Technologies Holdings Inc.

Evolv Technologies Holdings Inc is a security technology company pioneering Artificial Intelligence (AI)-powered screening solutions designed to help create safer environments while maintaining efficient visitor flow and a positive visitor experience. It serves customers across a range of end markets, including education, healthcare, sports, live entertainment, tourist attractions, houses of worship, and industrial workplaces. The company operates in a single segment that develops, manufactures, markets, and sells security screening products and specific services. Its products are used in different industries such as casinos, industrial workplaces, schools, and ticketed venues.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a biopharmaceutical company focused on the development and commercialization of medicines to improve patients lives. The company leverages decades of expertise and has developed FDA-approved YUPELRI (revefenacin) inhalation solution for the maintenance treatment of patients with COPD. Its ampreloxetine Phase 3 clinical study (CYPRESS) for the treatment of symptomatic neurogenic orthostatic hypotension in patients with multiple system atrophy did not meet its primary endpoint. The company operates in a single segment, the development and commercialization of human therapeutics, and operates in the United States, which generates maximum revenue, and Europe.

Share on Social Networks: